0

The full content of Annals is available to subscribers

Subscribe/Learn More  >
Articles |

Cancer-Associated Hypercalcemia: Morbidity and Mortality: Clinical Experience in 126 Treated Patients

Stuart H. Ralston, MB ChB, MD; Stephen J. Gallacher, MB ChB; Uday Patel, MB ChB; James Campbell, MB ChB; and Iain T. Boyle, BSC, MB ChB
[+] Article and Author Information

Grant Support: By Rorer Health Care, Eastbourne, United Kingdom.

Requests for Reprints: Stuart H. Ralston, MB ChB, MD, Rheumatic Diseases Unit, Northern General Hospital, Edinburgh EH5 2DQ, United Kingdom.

Current Author Addresses: Dr. Ralston: Rheumatic Diseases Unit, Northern General Hospital, Edinburgh E-H5 2DQ, United Kingdom.

Drs. Boyle and Gallacher: University Department of Medicine, Glasgow Royal Infirmary, Glasgow G31 2ER, United Kingdom.

Dr. Campbell: Department of Respiratory Medicine, Glasgow Royal Infirmary, Glasgow G31 2ER, United Kingdom.

Dr. Patel: Radiology Department, Middlesex Hospital, London, United Kingdom.


© 1990 American College of PhysiciansAmerican College of Physicians


Ann Intern Med. 1990;112(7):499-504. doi:10.7326/0003-4819-112-7-499
Text Size: A A A

Study Objective: To review the effects of antihypercalcemic treatment on morbidity and mortality in cancer-associated hypercalcemia.

Design: Retrospective study of 126 consecutive patients with cancer-associated hypercalcemia.

Setting: Inpatient referrals from a teaching hospital in the United Kingdom.

Intervention: Medical antihypercalcemic therapy supplemented by specific anticancer therapy where possible.

Measurements and Main Results: Median survival was 30 days. Survival did not differ in patients treated with different antihypercalcemic regimens but was longer (median, 135 days; P < 0.001) in a subgroup of 26 patients for whom specific anticancer therapy was available. Polyuria and polydipsia improved after therapy in 83% of cases, central nervous system symptoms in 71%, constipation in 70%, nausea and vomiting in 56%, anorexia in 50%, and malaise and fatigue in 47% (all significant, P < 0.001, pre-treatment compared with post-treatment). Pain control improved in only 23% of cases (not significant). Only 7% of patients with post-treatment serum calcium values above 3.50 mmol/L improved clinically compared with 80% whose calcium values fell below 2.80 mmol/L ( P < 0.001). Corresponding figures for the proportion of patients discharged from the hospital were 0% and 68% (P < 0.001).

Conclusions: Life expectancy is poor in cancer-associated hypercalcemia even in patients who are actively treated. Antihypercalcemic therapy has an important palliative role, however, because symptoms are usually improved and, in many cases, patients may be made well enough to be discharged from the hospital during the terminal stages of their illness.

Figures

Tables

References

Letters

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Comments

Submit a Comment
Submit a Comment

Summary for Patients

Clinical Slide Sets

Terms of Use

The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.

Toolkit

Buy Now

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Advertisement
Related Articles
Related Point of Care
Topic Collections
PubMed Articles
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)